Wiley-Blackwell, the scientific, technical, medical and scholarly publishing business of John Wiley & Sons, Inc., and EMBO today announced that EMBO Molecular Medicine will, as of March 2012, join the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results